2 Results for "

imatinib-resistant Bcr-Abl

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "imatinib-resistant Bcr-Abl" in MCE Product Catalog:

Cat. No.: HY-164469
CAS No.: 2479290-65-6
Target:  

Bcr-Abl Apoptosis STAT

Research Areas:  

Cancer

CHMFL-48 is an orally active BCR-ABL kinase inhibitor targeting both wild-type (wt) and various imatinib-resistant mutants. The IC50 values for CHMFL-48 against ABL wild-type and ABL T315I mutant are 1 nM and 0.8 nM, respectively. CHMFL-48 exerts its effects by blocking the autophosphorylation of BCR-ABL wild-type and mutant forms, which impacts downstream signaling mediators such as STAT5 and CRKL, leading to cell cycle arrest and induction of apoptosis. CHMFL-48 holds potential for research into chronic myeloid leukemia (CML) .
loading...
    loading...
Cat. No.: HY-112404
CAS No.: 607702-99-8
Target:  

Src Bcr-Abl

Research Areas:  

Cancer

BCR-ABL-IN-13 is a dual c-Src and Abl inhibitor, with a Ki value of 0.55 μM against c-Src, 0.10 μM against wild-type Abl, and 0.40 μM against the Abl T315I mutant. BCR-ABL-IN-13 exerts competitive/mixed-type inhibitory effects on wild-type Abl, and non-competitive inhibitory effects on the drug-resistant Abl T315I mutant. BCR-ABL-IN-13 can be used for the research of chronic myeloid leukemia .
loading...
    loading...